Newsroom

Sorted by: Latest

-

nLIGHT Announces Participation in Upcoming Investor Events

CAMAS, Wash.--(BUSINESS WIRE)--nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power lasers for mission critical directed energy, optical sensing, and advanced manufacturing applications, today announced management’s participation in several upcoming investor events during the third quarter of 2026. 15th Annual Needham Virtual Industrial Tech, Robotics, & Power 1x1 Conference Tuesday August 18, 2026 2026 Jefferies Semiconductor, IT Hardware & Communications Technology Conference...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 06.08.2026 FGOV LN IE00BKS2X200 83,638.00 GBP 1,240,415.26 17.313  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - March 06.08.2026 MMAR.LN IE0002PPCMH6 50,002.00 USD 1,339,893.33 26.797  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 06.08.2026 QDEC.LN IE000GAKWFA7 550,002.00 USD 13,487,843.84 24.523  ...
-

Coincheck Group N.V. To Participate at the KeyBanc Capital Markets Technology Leadership Forum

AMSTERDAM--(BUSINESS WIRE)--Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”), a Dutch public limited liability company that provides digital asset trade execution, custody, staking and asset management services, today announced that CEO, Pascal St-Jean and CFO, Jason Sandberg, will participate in a fireside chat at the KeyBanc Capital Markets Technology Leadership Forum in Park City, Utah on Tuesday, August 11, at 10:00 a.m. MT. A live webcast of the fireside chat will b...
-

Global Partners LP Reports Second-Quarter 2026 Financial Results

NEWTON, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) today reported financial results for the second quarter ended June 30, 2026. CEO Commentary “The second quarter was marked by strong contributions in all of our segments, with our business executing well in a dynamic market environment,” said Eric Slifka, the Partnership’s President and Chief Executive Officer. “The breadth of our liquid energy platform enables us to create and capture value across market conditions, as reflected in...
-

Teledyne Showcases End-to-End Defense and Space Solutions at the 2026 Space & Missile Defense Symposium

HUNTSVILLE, Ala.--(BUSINESS WIRE)--Teledyne will bring together a broad portfolio of technologies at the 2026 Space and Missile Defense Symposium, demonstrating how it supports some of the nation's most critical national security, space and missile defense missions. "Teledyne's strength lies in our ability to deliver mission-critical technologies across the defense and space ecosystem," said Scott Hall, President of Engineered Systems. "By combining expertise in sensing, imaging, microelectroni...
-

Viking Takes Delivery of Newest Egypt Ship

LOS ANGELES--(BUSINESS WIRE)--Viking® (www.viking.com) (NYSE: VIK) today announced it has taken delivery of the company’s newest river ship in Egypt, the Viking Ptah. The delivery ceremony for the Viking Ptah took place at Massara shipyard in Cairo, Egypt. “We are delighted to welcome the Viking Ptah to our growing fleet on the Nile River,” said Leah Talactac, President and CEO of Viking. “Egypt continues to inspire curious travelers from around the world, and with the addition of the Viking Pt...
-

bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung

SAN ANTONIO, Texas--(BUSINESS WIRE)--bioAffinity Technologies reported second quarter 2026 financial results and continued commercial momentum for CyPath® Lung test for lung cancer....